Mathieu M J Bertrand

19PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical infection agents (incl. prions)Synchrotrons and accelerators not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 24, 2026
Exosomal export of activated CASPASE-8 is linked to the prevention of TNF-induced cytotoxicity.

|Jan 16, 2026
ATG9A-dependent, LC3-independent autophagy curbs the immune system to protect against disease.

Dario Priem, Mathieu Jm Bertrand

|Sep 01, 2025
TAB2 controls a TAK1-independent cell death checkpoint at the level of TNFR1 complex II in the TNF pathway.

Tom Delanghe, Mike Vadi, Annelore Haems

|Nov 19, 2023
NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis.

Yves Dondelinger, Dario Priem, Jon Huyghe

|Apr 04, 2023
LC3-independent autophagy is vital to prevent TNF cytotoxicity.

Dario Priem, Jon Huyghe, Mathieu Jm Bertrand

|Dec 15, 2022
ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway.

Jon Huyghe, Dario Priem, Lisette Van Hove

Pageof 4

Frequent Collaborators

9 joint publications

Peter Vandenabeele

7 joint publications

Dario Priem

6 joint publications

Geert van Loo

4 joint publications

Jon Huyghe